Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical characteristics of COVID‐19 patients with hepatitis B virus infection — a retrospective study
Rui Liu, Li Zhao, Xiaoming Cheng, et al.
Liver International (2020) Vol. 41, Iss. 4, pp. 720-730
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation
Brit Long, Brandon M Carius, Summer Chavez, et al.
The American Journal of Emergency Medicine (2022) Vol. 54, pp. 46-57
Open Access | Times Cited: 222
Viral coinfections in COVID‐19
Parisa Shiri Aghbash, Narges Eslami, Milad Shirvaliloo, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 9, pp. 5310-5322
Open Access | Times Cited: 67
COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management
Penghui Li, Ying Liu, Ziqi Cheng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113568-113568
Open Access | Times Cited: 42
Current and Past Infections of HBV Do Not Increase Mortality in Patients With COVID‐19
Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong, Grace Lui, et al.
Hepatology (2021) Vol. 74, Iss. 4, pp. 1750-1765
Open Access | Times Cited: 51
Impact of COVID‐19 in Liver Disease Progression
Miguel Ángel Martı́nez, Sandra Franco
Hepatology Communications (2021) Vol. 5, Iss. 7, pp. 1138-1150
Open Access | Times Cited: 49
COVID-19 and the digestive system: A comprehensive review
Mingke Wang, Hai-Yan Yue, Jin Cai, et al.
World Journal of Clinical Cases (2021) Vol. 9, Iss. 16, pp. 3796-3813
Open Access | Times Cited: 44
Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases
Athanasios‐Dimitrios Bakasis, Kleopatra Bitzogli, Dimitrios Mouziouras, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 207-207
Open Access | Times Cited: 36
Management of hepatitis B virus reactivation due to treatment of COVID-19
Terry Cheuk‐Fung Yip, Madeleine Gill, Grace Lai‐Hung Wong, et al.
Hepatology International (2022) Vol. 16, Iss. 2, pp. 257-268
Open Access | Times Cited: 28
Outcomes of COVID-19 among patients with liver disease
Isidora S Vujcic
World Journal of Gastroenterology (2023) Vol. 29, Iss. 5, pp. 815-824
Open Access | Times Cited: 18
The Complexity of Co-Infections in the Era of COVID-19
Nevio Cimolai
SN Comprehensive Clinical Medicine (2021) Vol. 3, Iss. 7, pp. 1502-1514
Open Access | Times Cited: 36
Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis
Shanshan Yang, Shengshu Wang, Mingmei Du, et al.
Infectious Diseases and Therapy (2022) Vol. 11, Iss. 3, pp. 1229-1242
Open Access | Times Cited: 27
COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature
Caterina Sagnelli, Laura Montella, Pierantonio Grimaldi, et al.
Pathogens (2022) Vol. 11, Iss. 7, pp. 816-816
Open Access | Times Cited: 25
Leading Pathogens Involved in Co-Infection and Super-Infection with COVID-19: Forensic Medicine Considerations after a Systematic Review and Meta-Analysis
Roberto Scendoni, Emanuele Bury, Isabella Lima Arrais Ribeiro, et al.
Pathogens (2023) Vol. 12, Iss. 5, pp. 646-646
Open Access | Times Cited: 13
SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
Hendrik Luxenburger, Robert Thimme
Gut (2023) Vol. 72, Iss. 9, pp. 1783-1794
Open Access | Times Cited: 13
SARS-CoV-2 NSP12 Protein Is Not an Interferon-β Antagonist
Aixin Li, Kaitao Zhao, Bei Zhang, et al.
Journal of Virology (2021) Vol. 95, Iss. 17
Open Access | Times Cited: 28
Correlation between COVID-19 and hepatitis B: A systematic review
Yanfei He, Zhigang Jiang, Ni Wu, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 46, pp. 6599-6618
Open Access | Times Cited: 17
Effects of Hepatitis B Virus Infection on Patients with COVID-19: A Meta-Analysis
Yu Yang, Xingzhao Li, Taihu Wan
Digestive Diseases and Sciences (2022) Vol. 68, Iss. 4, pp. 1615-1631
Open Access | Times Cited: 16
Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges
Fares E.M. Ali, Zuhair M. Mohammedsaleh, Mahmoud Ali, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 15, pp. 1531-1552
Open Access | Times Cited: 22
Management of COVID-19 patients with chronic liver diseases and liver transplants
Xinyu Hu, Longyan Sun, Zhaoyang Guo, et al.
Annals of Hepatology (2021) Vol. 27, Iss. 1, pp. 100653-100653
Open Access | Times Cited: 21
Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients
Mahdie Rahban, Agata Stanek, Amirreza Hooshmand, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 21, pp. 4802-4802
Open Access | Times Cited: 20
T Cell Response to SARS-CoV-2 Coinfection and Comorbidities
Liqing Wang, Hao‐Yun Peng, Aspen Pham, et al.
Pathogens (2023) Vol. 12, Iss. 2, pp. 321-321
Open Access | Times Cited: 6
Italian association for the study of the liver position statement on SARS-CoV2 vaccination
Francesco Paolo Russo, Salvatore Piano, Raffaele Bruno, et al.
Digestive and Liver Disease (2021) Vol. 53, Iss. 6, pp. 677-681
Open Access | Times Cited: 15
The impact of HBV infection on clinical outcomes of COVID‐19 patients: a systematic review and meta-analysis
Yifan Guo, Xueling Zeng, Li Li, et al.
Epidemiology and Infection (2023) Vol. 151
Open Access | Times Cited: 5
Liver and COVID-19: From care of patients with liver diseases to liver injury
Rui Gaspar, C. Branco, Guilherme Macedo
World Journal of Hepatology (2021) Vol. 13, Iss. 10, pp. 1367-1377
Open Access | Times Cited: 11
Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19
Leonidas Brilakis, Eirini Theofilogiannakou, Panagis M. Lykoudis
World Journal of Gastroenterology (2024) Vol. 30, Iss. 11, pp. 1480-1487
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top